Acalabrutinib is Another BTK Inhibitor Active drug for Waldenstrom Macroglobulinemia - 102337

Spotlight
Video

Acalabrutinib is Another BTK Inhibitor Active drug for Waldenstrom Macroglobulinemia

Loading........
Description: Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains Acalabrutinib is Another BTK Inhibitor Active drug for Waldenstrom Macroglobulinemia at Annual Meeting 2018
Shared By : Annual-Meeting
Posted on : 06/04/18
Added : 12 months ago



Recommended

Nothing found.